Login

Brickworks Ltd MD Discusses Full Year Results, Property Trust, and Dividend Policy with Tom Piotrowski | Lindsay Partridge - CEO of brickworks ltd 00:10:00

Share On Facebook Share On Twitter

Lindsay Partridge is the CEO of brickworks ltd

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Nevada Copper's Path to Production: Insights from President and CEO Matthew Kelly at the One-to-One Mining Investment Conference in New York
00:10:00
Investing in companies committed to empowering small businesses|Arjan Schütte,Founder and Managing Partner,Core Innovation Capital
00:10:00
Al Maha Petroleum Products Marketing Company SAOG partners Vision Insurance Company | Hamed bin Salim bin Hamed Al-Maghdri, CEO, Al Maha Petroleum Products Marketing Co SAOGMHAS:MUS
00:10:00
Revitalizing Copper Production: Ascot Resources' Journey and Prospects at One-to-One Mining Conference
00:10:00
International Investment Forum (IIF) Offers Insightful Investment Trends and Strategies from Global Executives | Thomas Stümmler, CEO AT Vectron Systems AG
00:00:00
Anna Ljung, CEO, Moberg Pharma AB (publ)
00:10:00
"Insights from Dave Mazza, Head of Research for SPDR ETFs and SSGA Funds at State Street Global Advisors: An Interview with Tom Lydon on VettaFi"
00:10:00
The Value of Hiring a Financial Advisor: Objectivity and Expertise | Brooklyn Brock, Founder, Ellevate Advisors LLC.
00:10:00
"MoFo & BSR's ESG Influencers: Navigating Climate Disclosure Regulations"
00:10:00
The CBIZ, Inc. Property & Casualty group emphasizes prioritizing their people, making #TeamCBIZ stand out uniquely.
00:00:00
Alligator Bioscience at the ØU Lifescience Investor Conference, November 22, 2023 - Søren Bregenholt , CEO, Alligator Bioscience
00:10:00
Legal Insights: Panel with Evan Chesler and NYU Law Professors | Evan R. Chesler - RETIRED PARTNER of Cravath, Swaine & Moore LLP

© 2017 - Neuhu+